Delivery Order SPE2DB22D9239-SPE2DB25FDM03
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $16,483.21 to DMS Pharmaceutical Group Inc. for the supply of Cabometyx 40 mg tablets (30-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is scheduled for completion by August 20, 2025, and represents performance at the contractor's Park Ridge facility. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $16,434.34 to DMS Pharmaceutical Group Inc. for the supply of Cabometyx 60 mg tablets (30-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a direct procurement with no set-aside designation. The award reflects performance under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.9 billion...
- The Defense Logistics Agency awarded a delivery order valued at $32,966.42 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cabometyx 40 mg tablets (30-count units). This firm fixed-price delivery order, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The...
- The U.S. Defense Logistics Agency awarded a delivery order valued at $16,483.21 to DMS Pharmaceutical Group Inc. for the supply of Cabometyx 40 mg tablets (30-count units). This award, issued on August 19, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and will be performed at the contractor's facility in Park Ridge, Illinois. The contract utilizes no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,966.42 to DMS Pharmaceutical Group Inc. for the supply of Cabometyx 40 mg tablets (30-count units) on September 17, 2025, with completion targeted for September 18, 2025. This firm fixed-price delivery order, issued without a set-aside designation, leverages DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $33,000 to DMS Pharmaceutical Group Inc. for the supply of Cabometyx 40 mg tablets (30-count units) with an ultimate completion date of September 22, 2025. This firm fixed-price delivery order was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $500 million single-award contract valid through November 2026 that enables the agency to...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $16,483.21 for Cabometyx 40 mg tablets (30-count units). The contract, awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $16,483.21 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cabometyx 40 mg tablets (30-count units). This firm fixed-price delivery order, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a typical transactional procurement under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $33,265.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cabometyx 20 mg tablets (30-count units). This firm fixed-price delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a direct pharmaceutical supply fulfillment under DLA's pharmaceutical distribution operations. DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,434.34 by the Defense Logistics Agency on July 30, 2025, for the supply of Cabometyx 60 mg tablets (30-count units). The delivery order is issued without a set-aside designation and is scheduled for completion by July 31, 2025. This award falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDM03Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $32,868.70 to DMS Pharmaceutical Group Inc. for the supply of Cabometyx 60 mg tablets (30-count units). This firm fixed-price delivery order, issued on September 19, 2025, represents fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and extending through November 2026. The delivery is scheduled for completion by September 22, 2025, with performance occurring at the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected without a set-aside designation, competing on its merits as an established supplier within the federal pharmaceutical supply chain. The company serves as a critical distributor of prescription medications, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. Cabometyx, an oncology pharmaceutical, aligns with the company's demonstrated portfolio of supplying specialized pharmaceutical products to military health systems. This delivery order exemplifies the ongoing reliance on DMS Pharmaceutical Group's capabilities to support medical supply needs across the defense healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.9k | 9/19/25 |